Viewing Study NCT07380633


Ignite Creation Date: 2026-03-26 @ 3:19 PM
Ignite Modification Date: 2026-03-31 @ 12:35 PM
Study NCT ID: NCT07380633
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2026-02-02
First Post: 2026-01-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Toripalimab Plus Bevacizumab Combined Three Intra-arterial Therapies (TACE, HAIC, or TACE-HAIC) for Unresectable Hepatocellular Carcinoma: a Phase 2, Multicenter Randomised Non-comparative Trial
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module